{"id":"https://openalex.org/W4396596919","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps14-01","title":"Abstract PS14-01: Immune related adverse events in patients \u226565 years vs. <65 years with breast cancer treated with immunotherapy","display_name":"Abstract PS14-01: Immune related adverse events in patients \u226565 years vs. <65 years with breast cancer treated with immunotherapy","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396596919","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps14-01"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs23-ps14-01","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps14-01","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-ps14-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039802529","display_name":"Neelima Vidula","orcid":"https://orcid.org/0000-0002-5963-7052","observed_orcids":["https://orcid.org/0000-0002-5963-7052"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neelima Vidula","raw_affiliation_strings":["1Harvard Medical School, Massachusetts General, Boston, Massachusetts, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Harvard Medical School, Massachusetts General, Boston, Massachusetts, United States;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023123154","display_name":"Jennifer A. Hutchinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Hutchinson","raw_affiliation_strings":["2Massachusetts General Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Massachusetts General Hospital;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Abigail McLaren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abigail McLaren","raw_affiliation_strings":["2Massachusetts General Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Massachusetts General Hospital;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043140897","display_name":"Lianne Y. Ryan","orcid":"https://orcid.org/0009-0009-1898-550X","observed_orcids":["https://orcid.org/0009-0009-1898-550X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lianne Ryan","raw_affiliation_strings":["3Cancer Center, Massachusetts General Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cancer Center, Massachusetts General Hospital;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028403057","display_name":"Andrzej Niemierko","orcid":"https://orcid.org/0000-0002-8895-5500","observed_orcids":["https://orcid.org/0000-0002-8895-5500"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrzej Niemierko","raw_affiliation_strings":["2Massachusetts General Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Massachusetts General Hospital;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["4Massachusetts General Hospital Cancer Center, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Massachusetts General Hospital Cancer Center, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"9_Supplement","first_page":"PS14","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9559999704360962},{"id":"https://openalex.org/keywords/immunotherapy-toxicity","display_name":"immunotherapy toxicity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8669999837875366},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":1.0},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9660000205039978},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.6769999861717224},{"id":"https://openalex.org/keywords/age-differences","display_name":"age differences","score":0.4050000011920929},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.8360000252723694},{"id":"https://openalex.org/keywords/pneumonitis","display_name":"pneumonitis","score":0.6949999928474426},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.4580000042915344},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.5239999890327454},{"id":"https://openalex.org/keywords/immunotherapy-duration","display_name":"immunotherapy duration","score":0.4050000011920929},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.810339093208313},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6978738307952881},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.660038411617279},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.65965336561203},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6578166484832764},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6040303707122803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5691264271736145},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5478366613388062},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.278187096118927}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs23-ps14-01","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps14-01","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-ps14-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7129767152","https://openalex.org/W7155107819","https://openalex.org/W4399346145","https://openalex.org/W4416075565","https://openalex.org/W4411291268","https://openalex.org/W7129207558","https://openalex.org/W4281691679","https://openalex.org/W3166557703","https://openalex.org/W2891179139","https://openalex.org/W2890894484"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Pembrolizumab":[2],"is":[3,36,505],"approved":[4,16],"for":[5,17,172,177,202,229,233,380,476],"early/advanced":[6],"triple":[7],"negative":[8],"breast":[9,68,87,167,539],"cancer":[10,69,88,168,540],"(TNBC),":[11],"and":[12,24,50,63,82,114,130,152,175,231,294,424,459,473,486],"atezolizumab":[13],"was":[14,108,170,185,192,217],"previously":[15],"advanced":[18],"TNBC.":[19],"Toxicity":[20],"of":[21,212,226,258,277,333,346,355,358,382,451,470,510,547],"immunotherapy":[22,543],"(IO)":[23],"immune":[25],"related":[26,436,528],"adverse":[27,529],"events":[28,530],"(irAEs)":[29],"in":[30,39,41,65,84,188,219,238,274,430,438,455,501,531],"patients":[31,53,66,85,140,154,220,239,299,327,348,373,386,456,464,479,532],"\u226565":[32,54,70,89,141,173,240,302,328,374,399,441,457,465,533],"years":[33,55,71,90,94,142,157,174,282,329,375,389,458,466,482,534,537],"with":[34,67,86,124,433,538,542],"TNBC":[35],"not":[37,245],"described":[38],"detail":[40],"results":[42],"from":[43,426],"registration":[44],"trials":[45],"(KEYNOTE":[46],"522,":[47],"KEYNOTE":[48],"355,":[49],"IMPassion130),":[51],"where":[52],"were":[56,122,235,260,272,360,428,453],"a":[57,502],"minority.":[58],"Understanding":[59],"real-world":[60,446],"IO":[61,80,96,100,112,191,204,213,215,227,511],"toxicity":[62,81,113,230,234],"irAEs":[64,83,115,259,359,423,427,452],"may":[72],"inform":[73],"clinical":[74],"decision":[75],"making.":[76],"Methods:":[77],"We":[78],"studied":[79],"vs.":[91,206,535],"<":[92,155,178,198,221,265,280,289,313,339,367,387,409,460,480],"65":[93,156,179,199,222,266,281,290,314,340,368,388,410,461,481],"(at":[95],"start)":[97],"who":[98],"received":[99],"at":[101],"an":[102],"academic":[103],"institution.":[104],"A":[105],"retrospective":[106],"review":[107],"conducted":[109],"to":[110,251],"identify":[111],"(classified":[116],"by":[117],"CTCAE":[118],"v":[119],"5.0).":[120],"Cohorts":[121,137],"compared":[123],"Pearson's":[125],"chi-squared":[126],"test":[127,133],"(categorical":[128],"variables)":[129],"Wilcoxon":[131],"rank-sum":[132],"(continuous":[134],"variables).":[135],"Results:":[136],"had":[138,283,330,349,376,467,483],"25":[139],"(median":[143,158],"age":[144,159,497],"73":[145],"years,":[146,161,241],"interquartile":[147],"range":[148],"(IQR)":[149],"69-74":[150],"years)":[151],"104":[153],"48":[160],"IQR":[162],"39-56":[163],"years).":[164],"Stage":[165],"I-III/IV":[166],"distribution":[169],"36%/64%":[171],"68%/32%":[176],"years.":[180,223,442,462],"Baseline":[181],"ECOG":[182],"performance":[183],"status":[184],"mainly":[186,193],"0-1":[187],"both":[189,431],"cohorts.":[190],"pembrolizumab":[194],"(\u226565":[195,262,286,336,364],"years:":[196,200,263,267,287,291,303,315,337,341,365,369,400,411],"96%;":[197],"83%":[201],"first":[203,383],"regimen)":[205],"atezolizumab.":[207],"Table":[208,507],"1":[209,434],"depicts":[210],"characteristics":[211],"toxicity.":[214,512],"duration":[216],"longer":[218],"While":[224],"rates":[225,257,332,450,469],"interruption":[228],"discontinuation":[232],"numerically":[236],"higher":[237,331,468,487],"these":[242,496],"findings":[243],"did":[244],"reach":[246],"statisticial":[247],"significance,":[248],"possibly":[249],"due":[250],"the":[252,275,347,439,548],"sample":[253],"size.":[254],"Similar":[255],"overall":[256,449],"seen":[261],"72%;":[264],"65%,":[268],"p=0.47)":[269],"but":[270,372],"there":[271],"differences":[273],"types":[276],"irAEs.":[278],"Patients":[279],"more":[284,377,391,484,491],"transaminitis":[285,485],"12%;":[288,338],"33%,":[292],"p=0.04),":[293],"grade":[295,304,307,310,316,319,322,488],"2-3":[296],"hypothyroidism":[297],"(among":[298],"developing":[300],"hypothyroidism,":[301,489],"1-":[305,317],"75%,":[306],"2-":[308,320],"25%,":[309,416],"3-":[311,323],"0%;":[312],"11%,":[318,324],"79%,":[321],"p=0.017).":[325],"Conversely,":[326],"irAE":[334,384,396,435,471],"nephritis":[335,472],"1%,":[342],"p=0.004);":[343],"notably,":[344],"none":[345],"baseline":[350],"chronic":[351],"kidney":[352],"disease.":[353],"Rates":[354],"full":[356],"resolution":[357],"similar":[361,448],"between":[362],"cohorts":[363],"67%;":[366],"57%,":[370],"p=0.47),":[371],"steroid":[378,474],"use":[379,475],"management":[381,397],"while":[385,478],"required":[390],"thyroid":[392,403,414,492],"hormone":[393,493],"supplementation":[394],"(first":[395],"distribution,":[398],"steroids-":[401,412],"71%,":[402],"hormone-":[404,415],"7%,":[405],"supportive":[406,417],"care-":[407,418],"21%;":[408],"31%,":[413],"44%,":[419],"p=0.025).":[420],"Late":[421],"onset":[422],"deaths":[425],"rare":[429],"cohorts,":[432],"death":[437],"cohort":[440,504],"Conclusions:":[443],"In":[444],"this":[445],"cohort,":[447],"observed":[454],"However,":[463],"irAEs,":[477],"requiring":[490],"supplementation.":[494],"Given":[495],"specific":[498],"differences,":[499],"validation":[500],"larger":[503],"merited.":[506],"1.":[508],"Characteristics":[509],"Citation":[513],"Format:":[514],"Neelima":[515],"Vidula,":[516],"Jennifer":[517],"Hutchinson,":[518],"Abigail":[519],"McLaren,":[520],"Lianne":[521],"Ryan,":[522],"Andrzej":[523],"Niemierko,":[524],"Aditya":[525],"Bardia.":[526],"Immune":[527],"<65":[536],"treated":[541],"[abstract].":[544],"In:":[545],"Proceedings":[546],"2023":[549,555],"San":[550,558],"Antonio":[551],"Breast":[552],"Cancer":[553,564],"Symposium;":[554],"Dec":[556],"5-9;":[557],"Antonio,":[559],"TX.":[560],"Philadelphia":[561],"(PA):":[562],"AACR;":[563],"Res":[565],"2024;84(9":[566],"Suppl):Abstract":[567],"nr":[568],"PS14-01.":[569]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2024-05-03T00:00:00"}